Literature DB >> 34247428

A Biomimetic Aggregation-Induced Emission Photosensitizer with Antigen-Presenting and Hitchhiking Function for Lipid Droplet Targeted Photodynamic Immunotherapy.

Xiuli Xu1,2, Guanjun Deng1,3, Zhihong Sun1,3,4, Yuan Luo1,3, Junkai Liu3, Xinghua Yu1,3, Yang Zhao5, Ping Gong1, Guozhen Liu6,7, Pengfei Zhang1,3,8, Fan Pan1,9, Lintao Cai1,10, Ben Zhong Tang3,8,11.   

Abstract

Photodynamic therapy (PDT) is a promising alternative approach for effective cancer treatment that is associated with an antitumor immune response. However, immunosuppression of the tumor microenvironment limits the immune response induced by PDT. Stimulation and proliferation of T cells is a critical step for generating immune responses and depends on the efficient presentation of tumor antigens and co-stimulatory molecules by antigen-presenting cells (APCs). Here, biomimetic aggregation-induced emission (AIE) photosensitizers with antigen-presenting and hitchhiking abilities (DC@AIEdots) are developed by coating dendritic cell (DC) membranes on the nanoaggregates of the AIEgens. Notably, the inner AIE molecules can selectively accumulate in lipid droplets of tumor cells, and the outer cell membrane can facilitate the hitchhiking of DC@AIEdots onto the endogenous T cells and enhance the tumor delivery efficiency by about 1.6 times. Furthermore, DC@AIEdots can stimulate the in vivo proliferation and activation of T cells and trigger the immune system. The potential applications of therapeutic agents targeting lipid droplets for immunotherapy are indicated and a new hitchhiking approach for drug delivery is provided. Lastly, the study presents a photoactive and artificial antigen-presenting platform for effective T cell stimulation and cancer photodynamic immunotherapy.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  aggregation-induced emission; antigen presenting functions; lipid droplets; photodynamic immunotherapy; photosensitizers

Mesh:

Substances:

Year:  2021        PMID: 34247428     DOI: 10.1002/adma.202102322

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  3 in total

1.  Erythrocyte membrane-camouflaged nanoparticles as effective and biocompatible platform: Either autologous or allogeneic erythrocyte-derived.

Authors:  Jun Dai; Zhaojun Chen; Shixuan Wang; Fan Xia; Xiaoding Lou
Journal:  Mater Today Bio       Date:  2022-05-05

2.  Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery.

Authors:  Wenyan Hao; Yuexin Cui; Yueyue Fan; Mengyu Chen; Guobao Yang; Yuli Wang; Meiyan Yang; Zhiping Li; Wei Gong; Yang Yang; Chunsheng Gao
Journal:  J Nanobiotechnology       Date:  2021-11-20       Impact factor: 10.435

Review 3.  Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy.

Authors:  Tingting Zhang; Yushan Yang; Li Huang; Ying Liu; Gaowei Chong; Weimin Yin; Haiqing Dong; Yan Li; Yongyong Li
Journal:  Pharmaceutics       Date:  2022-03-29       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.